Empagliflozin and left atrial function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial
恩格列净对 2 型糖尿病合并冠状动脉疾病患者左心房功能的影响:来自 EMPA-HEART CardioLink-6 随机临床试验的启示
期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-024-02344-6
Pourafkari, Marina; Connelly, Kim A; Verma, Subodh; Mazer, C David; Teoh, Hwee; Quan, Adrian; Goodman, Shaun G; Rai, Archana; Ng, Ming Yen; Deva, Djeven P; Triverio, Piero; Jiminez-Juan, Laura; Yan, Andrew T; Ge, Yin